Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

Sponsor
University Hospital, Brest
Study ID
NCT06715267
Status
Recruiting
Apply to this trial

Conditions

  • Myeloproliferative Neoplasm

Eligibility Criteria

Sex
ALL
Age
0 Years - 30 Years
Healthy Volunteers
Not accepted

Study Details

The creation of a national database will provide access to solid data on the diagnosis of myeloproliferative neoplasia for patients under 30, giving a true picture of their care. It will also make it possible to identify the biological samples (histological and molecular) available in routine laboratories, enabling teams of researchers and anatomopathologists to (re)perform certain analyses to re-evaluate diagnoses and search for hitherto unknown molecular prognostic factors.

Key Dates

First listed
Dec 4, 2024
Start date
Apr 1, 2023
Status verified
Dec 2024
Primary completion
Apr 1, 2038
Completion
Apr 1, 2038

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Describe the epidemiological characteristics of the study population [ Time Frame: at enrollment ]

Central Contacts

Related Studies